Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PlcfiledCriticalBeecham Group Plc
Priority to MX9100974ApriorityCriticalpatent/MX9100974A/en
Publication of MX9100974ApublicationCriticalpatent/MX9100974A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Se describe una enzima fibrinolítica híbrida, su preparación, composiciones farmacéuticas que la contienen, y su uso en el tratamiento de enfermedades tromboembólicas, en particular en infarto agudo el miocardio.A hybrid fibrinolytic enzyme, its preparation, pharmaceutical compositions containing it, and its use in the treatment of thromboembolic diseases, in particular in acute myocardial infarction, are described.
MX9100974A1991-09-061991-09-06
HYBRID FIBRINOLYTIC ENZYME AND PROCEDURE FOR ITS PREPARATION.
MX9100974A
(en)
USE OF AMIODIPINE, A SALT OF THE SAME OR PHELODIPINE IN COMBINATION WITH AN ACE INHIBITOR IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF NON-ISCHEMICAL CONJUNCTIVE HEART FAILURE.